MedTrace Logo

An Analysis of Treatment Timelines for Lung Cancer Patients Across System Evolutions

NCT03535766 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2100

Last updated 2024-07-12

No results posted yet for this study

Summary

This study is a single center, minimal risk, physician initiated retrospective chart review. An analysis of treatment timelines for patients diagnosed with lung cancer within the St. Elizabeth system from January 2013 until study completion. The study investigator and designee(s) will review patient electronic medical records, extracting data related to the symptom presentation, diagnosis, and treatment of new diagnoses of lung cancer. Collected data will focus on dates of encounters, diagnostic imaging/procedures, and treatments, with data analysis evaluating time between care encounters and potential delays in care. The data will be further stratified based on system-wide changes implemented to improve efficiency, patient outcomes, and patient experience.

Conditions

Sponsors & Collaborators

  • St Elizabeth Healthcare

    lead OTHER

Principal Investigators

  • Royce Calhoun, MD · St Elizabeth Healthcare

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2021-07-01
Completion
2023-01-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03535766 on ClinicalTrials.gov